Unknown

Dataset Information

0

Physician and patient predictors of evidence-based prescribing in heart failure: a multilevel study.


ABSTRACT:

Background

The management of patients with heart failure (HF) needs to account for changeable and complex individual clinical characteristics. The use of renin angiotensin system inhibitors (RAAS-I) to target doses is recommended by guidelines. But physicians seemingly do not sufficiently follow this recommendation, while little is known about the physician and patient predictors of adherence.

Methods

To examine the coherence of primary care (PC) physicians' knowledge and self-perceived competencies regarding RAAS-I with their respective prescribing behavior being related to patient-associated barriers. Cross-sectional follow-up study after a randomized medical educational intervention trial with a seven month observation period. PC physicians (n?=?37) and patients with systolic HF (n?=?168) from practices in Baden-Wuerttemberg. Measurements were knowledge (blueprint-based multiple choice test), self-perceived competencies (questionnaire on global confidence in the therapy and on frequency of use of RAAS-I), and patient variables (age, gender, NYHA functional status, blood pressure, potassium level, renal function). Prescribing was collected from the trials' documentation. The target variable consisted of ?50% of recommended RAAS-I dosage being investigated by two-level logistic regression models.

Results

Patients (69% male, mean age 68.8 years) showed symptomatic and objectified left ventricular (NYHA II vs. III/IV: 51% vs. 49% and mean LVEF 33.3%) and renal (GFR<50%: 22%) impairment. Mean percentage of RAAS-I target dose was 47%, 59% of patients receiving ?50%. Determinants of improved prescribing of RAAS-I were patient age (OR 0.95, CI 0.92-0.99, p?=?0.01), physician's global self-confidence at follow-up (OR 1.09, CI 1.02-1.05, p?=?0.01) and NYHA class (II vs. III/IV) (OR 0.63, CI 0.38-1.05, p?=?0.08).

Conclusions

A change in physician's confidence as a predictor of RAAS-I dose increase is a new finding that might reflect an intervention effect of improved physicians' intention and that might foster novel strategies to improve safe evidence-based prescribing. These should include targeting knowledge, attitudes and skills.

SUBMITTER: Peters-Klimm F 

PROVIDER: S-EPMC3283612 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Physician and patient predictors of evidence-based prescribing in heart failure: a multilevel study.

Peters-Klimm Frank F   Laux Gunter G   Campbell Stephen S   Müller-Tasch Thomas T   Lossnitzer Nicole N   Schultz Jobst-Hendrik JH   Remppis Andrew A   Jünger Jana J   Nikendei Christoph C  

PloS one 20120221 2


<h4>Background</h4>The management of patients with heart failure (HF) needs to account for changeable and complex individual clinical characteristics. The use of renin angiotensin system inhibitors (RAAS-I) to target doses is recommended by guidelines. But physicians seemingly do not sufficiently follow this recommendation, while little is known about the physician and patient predictors of adherence.<h4>Methods</h4>To examine the coherence of primary care (PC) physicians' knowledge and self-per  ...[more]

Similar Datasets

| S-EPMC2796176 | biostudies-literature
| S-EPMC8401102 | biostudies-literature
| S-EPMC6396292 | biostudies-literature
| S-EPMC7521627 | biostudies-literature
| S-EPMC8915339 | biostudies-literature
| S-EPMC8080140 | biostudies-literature
| S-EPMC6662356 | biostudies-literature
| S-EPMC9021943 | biostudies-literature
| S-EPMC2518009 | biostudies-other
| S-EPMC6505404 | biostudies-literature